Colitis, Ulcerative: all 1,530 studies

Page 8 of 16. Open to participants first (407), then studies with results posted, then the rest; newest registration first within each.

• Composite Ratios Boost CRP's Power in Monitoring Ulcerative Colitis.CompletedNCT07261579
• A Study on Infections in Adults With Ulcerative Colitis/Crohn's DiseaseWithdrawnNCT07250815
• CurQD as Add-On Therapy in Vedolizumab-Treated Ulcerative Colitis Patients: Retrospective Cohort StudyActive, not recruitingNCT07240168
• The Role of CALLY and HAALP in Ulcerative ColitisCompletedNCT07236333
• A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS)TerminatedNCT07222189Phase 2
• Comparative Outcomes of Ulcerative Colitis Patients With Mayo Endoscopic Score 1 and Histologic Activity Versus Mayo Endoscopic Score 2CompletedNCT07188727
• Microbiota and Probiotic Therapy in Ulcerative Colitis PatientsCompletedNCT07180186
• Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis PopulationActive, not recruitingNCT07177209
• The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease PatientsActive, not recruitingNCT07177157Phase 1
• Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled StudyActive, not recruitingNCT07149441Not applicable
• Rutin Therapy Role in Reducing Ulcerative Colitis SeverityCompletedNCT07147842Not applicable
• Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel DiseaseActive, not recruitingNCT07123350
• Ulcer Pomegranate MuffinsCompletedNCT07123259Not applicable
• ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy SubjectsCompletedNCT07089420
• A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT07035041Phase 2
• A First-in-Human Study of BB-TL1A-VIAL-HLE in Healthy Adults and People With Ulcerative ColitisTerminatedNCT07029971Phase 1
• A Single-Center Observational Study on the Impact of Symptom Assessment Timing on the Short-Term Efficacy of 5-ASA Therapy in Patients With Initial-Onset or Relapsed Mild-to-Moderate Active Ulcerative ColitisCompletedNCT06998693
• Impact of the Novel UC-TREAT Diet on the Gut Microbiome and Its Acceptability in Healthy Adults and Adults With Quiescent Ulcerative ColitisCompletedNCT06998277Not applicable
• A Study to Investigate the Efficacy and Safety of Brivekimig in Adult Participants With Ulcerative ColitisActive, not recruitingNCT06975722Phase 2
• A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical PracticeActive, not recruitingNCT06964113Phase 4
• An Analysis of the Relationship Between the Genetic Polymorphisms of Plasminogen Activator Inhibitor-1 and Ulcerative Colitis in Chinese PatientsCompletedNCT06961435
• Upadacitinib for Refractory IBD in Asian Children and Elderly: Age-Stratified AnalysisCompletedNCT06922331
• Carotegrast Methyl in Ulcerative ColitisCompletedNCT06897150Phase 4
• A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to VedolizumabActive, not recruitingNCT06880744Phase 3
• The Associations of Microribonucleic Acid Gene Polymorphisms With the Risk of Ulcerative ColitisCompletedNCT06873711
• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisTerminatedNCT06867094Phase 2
• the Long-term Retention Rate and Influence Factors of Individualized Treatment of Vedolizumab in Ulcerative ColitisCompletedNCT06856031
• An Exploration of the Relationship Between Serum Cytokine Levels and the Clinical Efficacy of VedolizumabCompletedNCT06855862
• Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002)CompletedNCT06829225Phase 1
• Nutritional Counseling Impact on Ulcerative Colitis PatientsCompletedNCT06824038Not applicable
• A Direct Head-to-head Comparison of Ustekinumab With Infliximab for the Treatment of Ulcerative ColitisActive, not recruitingNCT06786507
• Open Label Study to Assess Safety & Efficacy of QD for Induction of Remission in Pediatric Patients with UCCompletedNCT06777706Not applicable
• Assessing Interventions of Diet in IBDCompletedNCT06773182Not applicable
• Chronic Care Model on Symptom Status, Stress and Quality of Life in Individuals With Inflammatory Bowel DiseaseActive, not recruitingNCT06757231Not applicable
• Whey Protein Milk-Derived ExosomesCompletedNCT06755021Not applicable
• Development and Validation of a New Paediatric Inflammatory Bowel Disease NUTrition Risk Score (PIBD-NUTS)Active, not recruitingNCT06723418
• Comparing TRIple Rectal Ultrasound Imaging Technology in Ulcerative ColitisCompletedNCT06717906Not applicable
• Mirikizumab Real World ProtocolTerminatedNCT06696014
• A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative ColitisTerminatedNCT06681389Phase 1
• A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy ParticipantsActive, not recruitingNCT06681181Phase 1
• Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients.CompletedNCT06663605Phase 1
• Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative ColitisCompletedNCT06652464
• Exploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome DisabilityCompletedNCT06646757Not applicable
• Association Between Effectiveness of Mirikizumab and UC Patients With High Neutrophilic Infiltration in Epithelium of the Colonic MucosaCompletedNCT06626165Phase 4
• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT06598943Phase 2
• A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune DiseaseCompletedNCT06587828
• Parasitic Infections and Ulcerative Colitis: Combining Anti-parasitic and Immunomodulatory Treatments May Achieve RemissionCompletedNCT06583863Not applicable
• A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative ColitisCompletedNCT06582264Phase 1
• Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel DiseaseCompletedNCT06575660Not applicable
• Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and EntyvioTerminatedNCT06570772Phase 3
• Role of Intestinal Ultrasound in Treat to Target Strategy in the Management of Inflammatory Bowel Disease : the IUS-TTT StudyActive, not recruitingNCT06534216
• Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy SubjectsCompletedNCT06528665
• The Role of Gut Bacteria in the Immune Response to Vaccination in Patients With Ulcerative ColitisActive, not recruitingNCT06504784Not applicable
• Retrospective Analysis of Systemic Glucocorticoid Mediated Long-term Effects, Patient Pathways and Economic Burden Across Multiple IndicationsCompletedNCT06488703
• Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's DiseaseCompletedNCT06459297
• Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative ColitisCompletedNCT06449820
• Prevalence and Factors Associated With Sleep Disorders in Inflammatory Bowel DiseaseCompletedNCT06439641Not applicable
• A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral AminosalicylatesCompletedNCT06398808Phase 2
• Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel DiseaseCompletedNCT06381518Not applicable
• A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy ParticipantsCompletedNCT06363383Phase 1
• Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis PatientsActive, not recruitingNCT06353828Phase 2
• A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel DiseaseCompletedNCT06346288Phase 4
• Trial of Mirtazapine for Depression in IBDCompletedNCT06309472Phase 2
• A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative ColitisActive, not recruitingNCT06294925
• Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT06290934Phase 2
• A Study of AK101 in Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT06281704Phase 1
• Comparison Between Infliximab and Adalimumab on Patients With Ulcerative ColitisCompletedNCT06269185
• A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative ColitisWithdrawnNCT06260267Phase 1
• A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT06260163Phase 3
• A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative ColitisActive, not recruitingNCT06257875Phase 2
• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT06254950Phase 2
• Effects of Gluten Free Diet in Ulcerative ColitisCompletedNCT06249763Not applicable
• Energy Expenditure in Patients With Ulcerative Colitis Undergoing SurgeryActive, not recruitingNCT06221995
• Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ StudyWithdrawnNCT06188637Phase 4
• A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)Active, not recruitingNCT06127043Phase 2
• A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their InfantsActive, not recruitingNCT06126835
• Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to BiologicsActive, not recruitingNCT06109441Phase 2
• IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD SymptomsCompletedNCT06094608Not applicable
• A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative ColitisCompletedNCT06080048Phase 1
• Alpha Lipoic Acid in Ulcerative ColitisCompletedNCT06067698Not applicable
• A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)Active, not recruitingNCT06052059Phase 3
• Prebiotics in Reducing Inflammation and Clinical Endpoints in Ulcerative Colitis (PRInCE-UC)CompletedNCT06050811Not applicable
• A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT06049017Phase 2
• Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCUCompletedNCT06031038Not applicable
• Improving Patient Outcomes Through the Implementation of an IBD Biologic Care PathwayWithdrawnNCT06030882Not applicable
• Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT06029972Phase 2
• Gluten-free Diet in PSC and IBDCompletedNCT06026449Not applicable
• SMART-IBD App TrialCompletedNCT06023667Not applicable
• Bleach and Urine Color in UC Patients Using 5ASAActive, not recruitingNCT06013696Not applicable
• A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy ParticipantsWithdrawnNCT05999708Phase 1
• A Personalized Approach to Abdominal Pain in Irritable Bowel SyndromeActive, not recruitingNCT05998577Not applicable
• Transfer of Feces in Ulcerative Colitis 2CompletedNCT05998213Phase 2
• ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASACompletedNCT05992142Phase 4
• A Study of LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC)CompletedNCT05975047Phase 1
• Exploration of the Activity of DNA Located Outside of Cellular Nucleus to Amplify Inflammation in Inflammatory Bowel Disease in Children Through Biological Pathway Cyclic GMP-AMP Synthase (cGAS) - Stimulator of Interferon Genes (STING)CompletedNCT05916274Not applicable
• The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.CompletedNCT05913817
• The Application of Transcriptomics in the Treatment of Ulcerative Colitis With UstekinumabCompletedNCT05896943
• CP101 for the Treatment of Ulcerative ColitisActive, not recruitingNCT05852574Phase 1
• First in Human, Single Ascending Dose StudyCompletedNCT05844592Phase 1
• An Early Phase 2 Clinical Study of KSP-0243CompletedNCT05831670Phase 2

← Colitis, Ulcerative overview